Latest News

Why Compounded Veterinary Medications Fall Short - Stability, Safety & Potency Risks in 2026 An Evidence-Based Review of Risks, Limitations, and Opportunities By Dr. Sarah Wade, Business Development & Alliance Manager This article was originally written for the 2026 Animal Health, Nutrition, and Technology Innovation Summit (AHNTI), where Eirgen Pharma was invited to contribute expert insights on a topic of their choice. We are pleased to share an expanded version for our br

Reflections from AHNTI 2026: Innovation, Customer-Centricity & The Evolving Landscape of Animal Health Last week, Eirgen Pharma attended the Animal Health, Nutrition and Technology Innovation Europe Summit ( AHNTI 2026)  for the first time as exhibitors. While it was our debut in this community, we’ve spent over a decade supporting both human and animal health companies in developing and manufacturing complex therapeutics. Being at AHNTI offered a unique chance to connect wi

We’re excited to share that Eirgen Pharma will be exhibiting at AHNTI 2026, taking place in London from March 2nd - 4th.